🇺🇸 FDA
Patent

US 8080527

Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection

granted A61KA61K31/05A61K31/085

Quick answer

US patent 8080527 (Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection) held by The Regents of the University of California expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/05, A61K31/085, A61K31/09, A61K31/135